Samaritan Pharmaceuticals Acquires Commercialization Rights to Market and Distribute Abiogen's Cancer Drug Abioklad in Greece, Cyprus and Turkey
19 mars 2008 09h20 HE
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, March 19, 2008 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals, Inc. (OTCBB:SPHC) (http://www.samaritanpharma.com), a biopharmaceutical company committed to commercializing new innovative...
Samaritan Signs Exclusive License to Commercialize Two of EUSA's Marketed Oncology Drugs in Greece and Cyprus
11 mars 2008 09h14 HE
|
Samaritan Pharmaceuticals, Inc.
Oncology Drugs ERWINASE and KIDROLASE Treat Acute Lymphoblastic
Leukemia (ALL)
Samaritan Expects Pipeline of 13 Marketed Products to Bring Company
Cash Flow Positive by 2009
LAS VEGAS, March...
Managing Director of Samaritan's European Operations Invited to Speak On Press Conference Panel in Recognition of 1st European Rare Disease Day
28 févr. 2008 10h19 HE
|
Samaritan Pharmaceuticals, Inc.
Samaritan's European Pharmaceutical Marketing Arm Gains Recognition
Panel Organized by Greek Ministry of Health and the Greek Alliance of Rare Diseases
LAS VEGAS, Feb. 28, 2008 (PRIME NEWSWIRE)...
Samaritan Therapeutics Names Entrepreneurial MD President
13 févr. 2008 09h29 HE
|
Samaritan Pharmaceuticals, Inc.
MONTREAL, Feb. 13, 2008 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals (OTCBB:SPHC) and Samaritan Therapeutics, a Montreal research and development biotech company, minority owned by Samaritan...
Samaritan Sales Revenue Growing
05 févr. 2008 09h04 HE
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Feb. 5, 2008 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals, Inc. (OTCBB:SPHC), a biopharmaceutical company committed to commercializing new innovative therapeutic drugs, is pleased to...
Huntington Disease Foundation to Assess Six of Samaritan's Drugs for Potential to Delay or Slow Progression of the Disease
24 janv. 2008 10h33 HE
|
Samaritan Pharmaceuticals, Inc.
CHDI Foundation's Initial Due Diligence Finds Neuroprotective Properties of Samaritan's Alzheimer's Drug's Intriguing
LAS VEGAS, Jan. 24, 2008 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals, Inc....
Samaritan Hires Expert Marketing Specialist to Build Up Southeast Europe Sales
22 janv. 2008 09h48 HE
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Jan. 22, 2008 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals, Inc. (OTCBB:SPHC) (http://www.samaritanpharma.com), a biopharmaceutical company focused on developing innovative therapeutics in...
Samaritan Pharmaceuticals Welcomes Two New Independent Directors to Its Board
07 janv. 2008 09h56 HE
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Jan. 7, 2008 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals, Inc. (OTCBB:SPHC), a biopharmaceutical company focused on developing innovative therapeutics in the areas of CNS, cancer,...
Samaritan Pharmaceuticals Anticipates Continued Growth in 2008
27 déc. 2007 10h15 HE
|
Samaritan Pharmaceuticals, Inc.
Management Proves Their Ability to Persist on Successful Path in 2007,
* Advanced Three Promising Breakthrough Drugs On Human Clinical Trial Path
* Successfully In-Licensed 11 Specialty...
Samaritan Pharmaceuticals Receives Pricing Approval in Greece for Hunters Syndrome Drug ELAPRASE
19 déc. 2007 10h43 HE
|
Samaritan Pharmaceuticals, Inc.
LAS VEGAS, Dec. 19, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals, Inc. (OTCBB:SPHC) (http://www.samaritanpharma.com), a biopharmaceutical company focused on developing innovative therapeutics in...